209 related articles for article (PubMed ID: 3087811)
1. [Mastopathy and breast cancer: is there a typical hormone profile?].
Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
[TBL] [Abstract][Full Text] [Related]
2. Serum hormones in human breast cancer subjects.
Krishnamoorthy G; Govindarajulu P; Ramalingam V
Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
[TBL] [Abstract][Full Text] [Related]
3. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
4. [GnRH-TRH stimulation tests in patients with mastopathy].
Kasch R; Meissner J; Kunkel S
Zentralbl Gynakol; 1988; 110(5):298-303. PubMed ID: 3131977
[TBL] [Abstract][Full Text] [Related]
5. [Rational hormone diagnosis in normocyclic functional sterility].
Moltz L; Leidenberger F; Weise C
Geburtshilfe Frauenheilkd; 1991 Sep; 51(9):756-68. PubMed ID: 1835948
[TBL] [Abstract][Full Text] [Related]
6. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
Sherman BM; Chapler FK; Crickard K; Wycoff D
J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
[TBL] [Abstract][Full Text] [Related]
7. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
[TBL] [Abstract][Full Text] [Related]
8. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
9. Serum prolactin levels in patients with fibrocystic breast disease.
Peters F; Schuth W; Scheurich B; Breckwoldt M
Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
[TBL] [Abstract][Full Text] [Related]
10. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism.
Szilágyi G; Szabolcs I; Vydra G; Góth M; Irsy G
Acta Med Hung; 1984; 41(4):175-83. PubMed ID: 6440114
[TBL] [Abstract][Full Text] [Related]
11. LRF and TRF test during long-term danazol treatment: increase of the LH and FSH responses but decrease of the prolactin and TSH responses.
Leppäluoto J; Rönnberg L; Ylöstalo P
Acta Endocrinol (Copenh); 1983 Sep; 104(1):1-5. PubMed ID: 6414205
[TBL] [Abstract][Full Text] [Related]
12. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
[TBL] [Abstract][Full Text] [Related]
13. Thyroid-stimulating hormone and prolactin levels in breast cancer.
Aldinger KA; Schultz PN; Blumenschein GR; Samaan NA
Arch Intern Med; 1978 Nov; 138(11):1638-41. PubMed ID: 102267
[TBL] [Abstract][Full Text] [Related]
14. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
[TBL] [Abstract][Full Text] [Related]
15. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins.
Rose DP; Boyar AP; Cohen C; Strong LE
J Natl Cancer Inst; 1987 Apr; 78(4):623-6. PubMed ID: 3104646
[TBL] [Abstract][Full Text] [Related]
16. [The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast].
Sieja K; Stanosz S
Ginekol Pol; 2002 Jul; 73(7):594-9. PubMed ID: 12375569
[TBL] [Abstract][Full Text] [Related]
17. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
[TBL] [Abstract][Full Text] [Related]
18. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast.
Dogliotti L; Faggiuolo R; Ferusso A; Orlandi F; Sandrucci S; Tibo A; Angeli A
Horm Res; 1985; 21(3):137-44. PubMed ID: 3922866
[TBL] [Abstract][Full Text] [Related]
20. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
